You definitely need to follow up with your physician(s) to discuss the specifics of the Intraductal carcinoma (IDC-P) found in your husband’s pathology report.
IDC-P is often associated with more aggressive prostate cancer.
Although some Gleason 3+4 can allow for active surveillance, the presence of IDC-P could shift the recommendation toward definitive treatments like surgery (prostatectomy) or radiation.
Here’s a few questions I’d be asking my urologist or oncologist, regarding the IDC-P finding:
• How extensive is the IDC-P, based on the current pathology report?
• Does the IDC-P observed in this report change the risk assessment in my particular diagnosis?
• Can you help me get a 2nd opinion on my biopsy pathology, especially focused on the severity of the IDC-P?
• Can additional tests (e.g., especially the Decipher genomic testing) help to assess the overall aggressiveness of the PCa, for my specific case?
• How does the current IDC-P finding, in my particular case, affect my treatment options or monitoring plans?
I wish you and your husband all the best, as you chart your path forward!
This is great advice. The only thing I would add is that getting a second opinion from John's Hopkins was easy (I did it online) and relatively cheap. ($300)
They upgraded me from a 3+4 to a 4+3.